Biaxin - antibacterial agent of group of macroleads, semi-synthetic derivative of erythromycin. Biaxin is prescribed for treatment of infectious processes caused by flora, sensitive to it: sinusitis, pharyngitis, tonsillitis; folliculitis, streptoderma, erysipelatous inflammation, staphyloderma; bronchitis, community-acquired or hospital-acquired pneumonia; infections of dentoalveolar system; local or widespread mycobacterial infections caused by Mycobacterium intracellulare or Mycobacterium avium; in a complex of medicine oppressing acidity of a gastric acid for eradication of Helicobacter infection.
An antimicrobial agent from the nitrofurans group, especially suitable for the treatment of urinary tract infections and prevention of infections after urologic surgery or examinations (cystoscopy, catheterization, etc.). The medicine disrupts the permeability of the cell membrane and protein synthesis in bacteria.
The drug is a prodrug and is activated in the acidic environment of the secretory tubules in the parietal cells. It reduces basal and stimulated secretion regardless of the nature of the stimulus. Prescribed in case of erosive ulcerative diseases of the gastrointestinal tract and eradication of Helicobacter pylori in infected patients with gastric and duodenal ulcer.